We are live on
!
Find out more
ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
387 hedge funds and large institutions have $8.08B invested in Intra-Cellular Therapies Inc. in 2024 Q4 according to their latest regulatory filings, with 69 funds opening new positions, 133 increasing their positions, 138 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
131% more call options, than puts
Call options by funds: $25.4M | Put options by funds: $11M
130% more first-time investments, than exits
New positions opened: 69 | Existing positions closed: 30
50% more funds holding in top 10
Funds holding in top 10: 10 → 15 (+5)
14% more capital invested
Capital invested by funds: $7.12B → $8.08B (+$963M)
9% more funds holding
Funds holding: 355 → 387 (+32)
4% less repeat investments, than reductions
Existing positions increased: 133 | Existing positions reduced: 138
Holders
387
Holders Change
+32
Holders Change %
+9.01%
% of All Funds
5.1%
Holding in Top 10
15
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+50%
% of All Funds
0.2%
New
69
Increased
133
Reduced
138
Closed
30
Calls
$25.4M
Puts
$11M
Net Calls
+$14.4M
Net Calls Change
+$1.74M
Top Buyers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$40.5M |
| 2 |
TCM
TimesSquare Capital Management
New York
|
+$33M |
| 3 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$32.8M |
| 4 |
D.E. Shaw & Co
New York
|
+$13.6M |
| 5 |
O
OrbiMed
New York
|
+$13.4M |
Top Sellers
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$49.3M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$39.4M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$37.2M |
| 4 |
PA
Perceptive Advisors
New York
|
-$27.4M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
-$14.9M |
